Drozitumab Biosimilar - Anti-CD262,TRAIL-R2,DR5 mAb - Research Grade, Human, Monoclonal
Artikelnummer:
PTG-PX-TA1243-100
- Bilder (0)
| Artikelname: | Drozitumab Biosimilar - Anti-CD262,TRAIL-R2,DR5 mAb - Research Grade, Human, Monoclonal |
| Artikelnummer: | PTG-PX-TA1243-100 |
| Hersteller Artikelnummer: | PX-TA1243-100 |
| Alternativnummer: | PTG-PX-TA1243-100 |
| Hersteller: | ProteoGenix |
| Wirt: | Human |
| Kategorie: | Antikörper |
| Spezies Reaktivität: | Human |
| Alternative Synonym: | Anti-CD262, Anti-TNFRSF10B, Anti-TRAIL-R2, PRO95780, anti-DR5, rhuMAb DR5, CAS: 912628-39-8 |
| Klonalität: | Monoclonal |
| UniProt: | O14763 |
| Puffer: | 0.01M PBS, pH 7.4. |
| Expression System: | Eukaryotic expression |
| Target-Kategorie: | CD262/TRAIL-R2/DR5 |
Produktgarantie und fachkundiger Support
